7SNI image
Entry Detail
PDB ID:
7SNI
EMDB ID:
Keywords:
Title:
Structure of G6PD-D200N tetramer bound to NADP+ and G6P
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2021-10-28
Release Date:
2022-07-13
Method Details:
Experimental Method:
Resolution:
2.50 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Glucose-6-phosphate 1-dehydrogenase
Chain IDs:A, B, C, D
Chain Length:523
Number of Molecules:4
Biological Source:Homo sapiens
Primary Citation
Allosteric role of a structural NADP + molecule in glucose-6-phosphate dehydrogenase activity.
Proc.Natl.Acad.Sci.USA 119 e2119695119 e2119695119 (2022)
PMID: 35858355 DOI: 10.1073/pnas.2119695119

Abstact

Human glucose-6-phosphate dehydrogenase (G6PD) is the main cellular source of NADPH, and thus plays a key role in maintaining reduced glutathione to protect cells from oxidative stress disorders such as hemolytic anemia. G6PD is a multimeric enzyme that uses the cofactors β-D-glucose 6-phosphate (G6P) and "catalytic" NADP+ (NADP+c), as well as a "structural" NADP+ (NADP+s) located ∼25 Å from the active site, to generate NADPH. While X-ray crystallographic and biochemical studies have revealed a role for NADP+s in maintaining the catalytic activity by stabilizing the multimeric G6PD conformation, other potential roles for NADP+s have not been evaluated. Here, we determined the high resolution cryo-electron microscopy structures of human wild-type G6PD in the absence of bound ligands and a catalytic G6PD-D200N mutant bound to NADP+c and NADP+s in the absence or presence of G6P. A comparison of these structures, together with previously reported structures, reveals that the unliganded human G6PD forms a mixture of dimers and tetramers with similar overall folds, and binding of NADP+s induces a structural ordering of a C-terminal extension region and allosterically regulates G6P binding and catalysis. These studies have implications for understanding G6PD deficiencies and for therapy of G6PD-mediated disorders.

Legend

Protein

Chemical

Disease

Primary Citation of related structures